Open access
Aug 2026
PACM-01 RECEPTOR-COMPLEX–SPECIFIC CD200 ACTIVATION RECEPTOR TARGETING DRIVES COMPARTMENT-SPECIFIC ANTI-TUMOR IMMUNITY IN BREAST CARCINOMA
This work establishes receptor-complex–specific CD200AR targeting as a strategy to generate spatially tailored antitumor immunity and supports further translational development of ARL200-based combination therapies for metastatic breast carcinoma involving the CNS.
S. Frederico, R. Bose, Lindsey Sloan et al.
· Neuro-Oncology Advances · 0 citations